253 related articles for article (PubMed ID: 8080726)
1. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
Stanton P; Richards S; Reeves J; Nikolic M; Edington K; Clark L; Robertson G; Souter D; Mitchell R; Hendler FJ
Br J Cancer; 1994 Sep; 70(3):427-33. PubMed ID: 8080726
[TBL] [Abstract][Full Text] [Related]
2. A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
Christensen ME; Engbaek F; Therkildsen MH; Bretlau P; Nexø E
Br J Cancer; 1995 Dec; 72(6):1487-93. PubMed ID: 8519664
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.
O-Charoenrat P; Rhys-Evans P; Modjtahedi H; Court W; Box G; Eccles S
Int J Cancer; 2000 May; 86(3):307-17. PubMed ID: 10760816
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines.
Weichselbaum RR; Dunphy EJ; Beckett MA; Tybor AG; Moran WJ; Goldman ME; Vokes EE; Panje WR
Head Neck; 1989; 11(5):437-42. PubMed ID: 2807884
[TBL] [Abstract][Full Text] [Related]
5. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of malignant oral rat keratinocytes reflects changes in EGF and TGF-beta receptor expression but not growth factor dependence.
Game SM; Stone A; Matthews JB; Scully C; Prime SS
Carcinogenesis; 1991 Mar; 12(3):409-16. PubMed ID: 1849051
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
9. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
[TBL] [Abstract][Full Text] [Related]
10. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.
Ishitoya J; Toriyama M; Oguchi N; Kitamura K; Ohshima M; Asano K; Yamamoto T
Br J Cancer; 1989 Apr; 59(4):559-62. PubMed ID: 2713242
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
Modjtahedi H; Hickish T; Nicolson M; Moore J; Styles J; Eccles S; Jackson E; Salter J; Sloane J; Spencer L; Priest K; Smith I; Dean C; Gore M
Br J Cancer; 1996 Jan; 73(2):228-35. PubMed ID: 8546911
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
[TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
[TBL] [Abstract][Full Text] [Related]
17. Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck.
Rikimaru K; Tadokoro K; Yamamoto T; Enomoto S; Tsuchida N
Head Neck; 1992; 14(1):8-13. PubMed ID: 1624295
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
19. Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs.
Li S; Hanna E; Breau R; Ratanatharathorn V; Xia X; Suen J
Br J Cancer; 2004 Mar; 90(5):1093-9. PubMed ID: 14997212
[TBL] [Abstract][Full Text] [Related]
20. PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.
van Dijk LK; Yim CB; Franssen GM; Kaanders JH; Rajander J; Solin O; Grönroos TJ; Boerman OC; Bussink J
Contrast Media Mol Imaging; 2016; 11(1):65-70. PubMed ID: 26242487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
